Accessibility Menu
Global Roundtable logo

Global Roundtable(OTC) GRCU

Current Price$0.00
Market Cap$7.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-100%
5 Year-100%
1 Year-99%
1 Month+0%
Global Roundtable last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-21
Global Roundtable stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-09
1 month+0%USD 0.002026-06-16
3 month+0%USD 0.002026-04-17
Year to date-99.33%USD 0.002025-12-31
1 year-99%USD 0.002025-07-21
3 year-99.75%USD 0.002023-07-21
5 year-99.98%USD 0.012021-07-22
Since inception-100%USD 598,002,941.182006-07-14

Global Roundtable Financials at a Glance

Market Cap

$7.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.30M

Net Income (TTM)

-$243.23K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

14.26 (High)

Price

$0.00

Volume

20,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 27, 2024

GRCU News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Global Roundtable

Global Roundtable Corporation is a healthcare company focused on providing health and wellness services and products. Formerly known as Green Cures & Botanical Distribution Inc., the company rebranded in May 2023 and has been operational since 1986, based in Denver, Colorado.

Products and Services
  • Health and wellness services tailored for diverse needs
  • Pharmaceutical products aimed at improving quality of life
  • Innovative solutions in the medical sector
Growth Outlook
  • Recent quarterly revenue increased significantly to $25,477
  • Gross profit margin improved to 68.8% in Q3 2024
  • Positive cash flow from operations of $316,515 in Q2 2024
Financial Highlights
  • Trailing twelve months revenue of $160,87 in Q4 2024
  • Net income of $288,365 reported in Q4 2023
  • Current ratio of 0.84 indicates liquidity management
Global Roundtable Corporation is positioned in the medical and pharmaceutical industry, focusing on health and wellness. The recent rebranding reflects a strategic shift towards a broader market appeal. The company has shown promising growth, particularly in its latest quarterly results, with a notable increase in revenue and gross profit margins. The positive cash flow from operations indicates effective management of resources, which is crucial for sustaining growth. Financial metrics such as the current ratio suggest a focus on maintaining liquidity, essential for navigating the competitive healthcare landscape. Overall, Global Roundtable Corporation presents an intriguing opportunity for investors interested in the healthcare sector.
AI Generated • Jul 16, 2026

Industry

Personal Products

CEO

Robert Tanko

Headquarters

Denver, CO 80231, US

GRCU Financials

Key Financial Metrics (TTM)

Gross Margin

36.81%

Operating Margin

-17.40%

Net Income Margin

-18.71%

Return on Equity

-34.98%

Return on Capital

-21.98%

Return on Assets

-11.95%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

7.23B

Volume

20.00K

Avg. Volume

318.58K

Financials (TTM)

Gross Profit

$478.63K

Operating Income

-$226.28K

EBITDA

-$186.45K

Operating Cash Flow

$411.94K

Capital Expenditure

$2.00

Free Cash Flow

$411.94K

Cash & ST Invst.

$362.96K

Total Debt

$373.35K

Global Roundtable Performance Analysis

Global Roundtable annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 135,861N/A
20222022-12-31USD 102,083-24.9%
20232023-12-31USD 2,250,4022104.5%
20242024-12-31USD 1,300,267-42.2%
Global Roundtable sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31-33.9%
Q22024-06-3048.6%
Q32024-09-30-96.6%
Q42024-12-31-36.9%
Global Roundtable annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.00N/A
20222022-12-31USD -0.000.0%
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
Global Roundtable sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31-186.4%
Q22024-06-30184.0%
Q32024-09-30-143.5%
Q42024-12-31-0.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$16.09K

-97.9%

Gross Profit

$4.10K

-99.2%

Gross Margin

25.47%

N/A

Market Cap

$7.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$360.00

N/A

Employees

20

N/A

Net Income

-$108.40K

-137.6%

EBITDA

-$100.68K

-126.8%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Total Cash

$362.96K

+75.9%

Total Debt

$373.35K

+2.6%

Accounts Receivable

$767.26K

+37.4%

Inventory

$29.19K

-15.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$373.35K

+2.6%

Return on Assets

-11.95%

N/A

Return on Invested Capital

-34.49%

N/A

Free Cash Flow

-$13.65K

+96.0%

Operating Cash Flow

-$13.65K

+96.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GEATFRadiko Holdings Corp
$0.00+0.00%
XBRAFXebra Brands Ltd.
$0.00+0.00%
STEKStemtech Corporation
$0.00+0.00%
FITXCreative Edge Nutrition, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About GRCU

What is the current price of Global Roundtable?

Global Roundtable is trading at $0.00 per share.

What is the 52-week range for Global Roundtable?

Over the past 52 weeks, Global Roundtable has traded between $0.00 and $0.00.

How much debt does Global Roundtable have?

As of the most recent reporting period, Global Roundtable reported total debt of $373.35K.

How much cash does Global Roundtable have on hand?

Global Roundtable reported $362.96K in cash and cash equivalents in its most recent financial results.

What is Global Roundtable’s dividend yield?

Global Roundtable does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.